Using DNA methylation microarray chip analysis, we identified the membrane protein RRBP1 as a tumor oncogene in UTUC cells, and the potential of RRBP1 as a clinical prognostic marker from The Cancer Genome Atlas (TCGA) BLCA database was further confirmed. The gene discussed is RRBP1; the disease is bladder transitional cell carcinoma.